Tagged with

Paris, November 20th, 2015 Synerlab pursues its consolidation strategy in Europe Synerlab, a leading pharmaceutical manufacturer, announces today the acquisition of Alcala Farma, a prominent Spanish contract development and manufacturing organization (CDMO). Alcala Farma specializes in the development of proprietary formulation, which represents nearly 40% of its total €M 25…

pharma Rikus Wolbers, Director at Novio Tech Campus, a key international incubator for R&D and manufacturing companies who are active at the interface of life sciences and high tech, and John Schalken, Program Director SMB Life Sciences, give an overview of the impressive developments in the Nijmegen area and the potential…

Mexico The following charts show manufacturing costs in the Medical Devices Industry (compared to the US in 2013) and Medical Device Exports from Mexico (in USD millions). For more data on the Mexican market, please download our latest 2015 free report here.

Mexico The below chart shows the average number of days taken to grant registration for innovative drugs. The previous number of days for Mexico (360) has been greatly reduced to 60 as of 2014. For more data on the Mexican market, please download our latest 2015 free report here.

Mexico The chart below shows the main investors into pharmaceuticals in Mexico and the main export destinations for Mexican pharmaceutical products. It also shows the production value, compound annual growth, and number of economic units in the Mexican pharmaceutical industry, as well as the number of jobs it creates and overall FDI. For more data on the Mexican…

This chart shows the manufacturing costs in the Mexican pharmaceutical industry (compared to the US in 2013). For more data on the Mexican market, please download our latest 2015 free report here.  

Pharma Bayer broke into the top ten multinationals in Egypt this year, after achieving a remarkable 110 percent growth over the last two years. General manager Hatem Safei discusses the developments that drove this strong expansion, and the overall potential he sees in the healthcare market going forward. What are the…

pharma Harnessing the power of big data and the Internet, myTomorrows is working to help patients in need to access treatments that would otherwise not be available outside of a clinical trial. CEO Ronald Brus discusses the workings of this unique and disruptive company. As an introduction, given your wealth of experience in…

Through greater government support for R&D, tax breaks for both foreign investors and domestic researchers and the creation of knowledge clusters, Thailand hopes to reposition itself as a regional R&D leader and pull itself out of the middle income trap. For a long time Thailand’s economy has been seen as…

Pharma After a successful IPO on Nasdaq in May 2015, Galapagos is ready to continue developing its robust portfolio of clinical-stage breakthrough therapies with the potential to revolutionize existing treatment paradigms. The CEO discusses his current priorities as well as his vision to transform Galapagos into a specialty pharmaceutical company. In…

Pharma Leo Le Duc, Director of Amsterdam Science Park, explains the potential of Amsterdam Science Park as a world-class eco-system for start-ups, mature companies, research centers and students, as well as how the largest beta-science cluster in Northern Europe will help to globally establish Amsterdam as a “City of Knowledge.”  You…

Pharma The CSO and COO of BioNovion talk about the company’s recent acquisition by US-based biotech Aduro. BioNovion is a Dutch biopharma specialized in immune oncology antibody discovery. Immunotherapy has become a clinical reality as an effective approach to treat advanced cancer and BioNovion plans to keep leveraging the fruitful collaboration with top-notch research centers…